Document:

Exhibit 10.13

THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR
UNDER ANY STATE SECURITIES LAW. THE SECURITIES MAY NOT BE OFFERED, SOLD, OR
OTHERWISE TRANSFERRED UNLESS THEY ARE REGISTERED UNDER THE ACT AND ALL
APPLICABLE STATE SECURITIES LAWS OR ARE OFFERED, SOLD, OR TRANSFERRED IN
COMPLIANCE WITH AN EXEMPTION THEREFROM.

                              CONVERTIBLE DEBENTURE

$250,000.00                                                      April ___, 2004

         FOR VALUE RECEIVED, VIRAL GENETICS, INC., a Delaware corporation (the
"Company"), promises to pay to the order of TOM LITTLE (the "Holder"), at 260
East Chestnut Street, Chicago, Illinois, 60611, or such other place as the
Holder may designate from time to time by notice to the Company, in coin or
currency of the United States of America that at the time of payment is legal
tender for the payment of public and private debts, the principal sum of Two
Hundred and Fifty Thousand and No/100's Dollars ($250,000.00).

         1. Maturity, Interest Rate. All principal shall be due and payable on
the earlier of (i) December 31, 2004, or (ii) any Event of Default (as defined
below). This Debenture shall not bear interest.

         2. Waiver of Demand. Protest, etc. The Company expressly waives demand
and presentment for payment, notice of nonpayment, protest, notice of protest,
notice of dishonor, notice of acceleration or intent to accelerate, bringing of
suit and diligence in taking any action to collect amounts called for hereunder
and shall be directly and primarily liable for the payment of all sums owing and
to be owing hereon, regardless of and without any notice, diligence, act or
omission as or with respect to the collection of any amount called for
hereunder.

         3. Prepayment. The Company may, at its election, prepay this Debenture
in whole or in part at any time after written notice from the Company to the
Lender given not less than 30 days nor more than 60 days prior to the date of
prepayment stated in the notice. From and after notice of prepayment is given to
Holder under this Section 3 the holder may exercise the exchange rights provided
for in Section 5, below.

         4. Default. On the occurrence of any one or more of the events
hereinafter enumerated (an "Event of Default") the entire unpaid balance of the
principal shall become immediately due and payable:

                                       1
<PAGE>

         (a) Default in the payment when due of any installment of principal on
this Debenture, whether as scheduled herein, at maturity, by acceleration, or
otherwise;

         (b) The Company shall default in the performance of any term or
covenant of this Debenture (other than a payment default contemplated by
subsection 4(a)), and such default remains uncured 30 days following written
notice thereof given by the Holder to the Company.

         (c) The Company shall (i) file a voluntary petition in bankruptcy or a
voluntary petition seeking reorganization; (ii) file an answer admitting the
jurisdiction of the court and any material allegations of an involuntary
petition filed pursuant to any act of Congress relating to bankruptcy or to any
act purporting to be amendatory thereof; (iii) make an assignment for the
benefit of creditors; (iv) apply for or consent to the appointment of any
receiver or trustee for the Company; or (v) make an assignment to an agent
authorized to liquidate any substantial part of the Company's business; or

         (d) An order shall be entered pursuant to any act of Congress relating
to bankruptcy or any act purporting to be amendatory thereof approving an
involuntary petition seeking reorganization of Company or an order of any court
shall be entered appointing any receiver or trustee of or for Company or of or
for all or any substantial portion of its property, and such order approving a
petition seeking reorganization or appointing a receiver or trustee is not
vacated or stayed or any writ, warrant of attachment, or similar process is not
released or bonded within sixty (60) days after its levy or entry.

         5. Exchange for Stock.

         (a) All or any part of the outstanding principal on this Debenture
shall be convertible, at the option of the Holder, at any time after notice of
prepayment is given under Section 3 and at any time after December 31, 2004 into
the number of fully paid and non-assessable shares of Common Stock which results
from dividing the "Conversion Price" in effect at the time of exchange into the
principal so to be converted. The Conversion Price shall be (as the same may be
adjusted under subsection 5(c)) the greater of $0.18 or 70 percent of the fair
market value per share of the Company's Common Stock as of the trading day
immediately preceding the day notice of exchange is given by Holder to the
Company. For purposes of this provision, the fair market value per share of the
Company's Common Stock on any relevant date shall be determined in accordance
with the following provisions:

                  (i) If the Common Stock is not at the time listed or admitted
to trading on any national securities exchange but is traded on the Nasdaq
National Market, the Fair Market Value shall be the mean between the highest
"bid" and lowest "offered" quotations of a share of Common Stock on such date
(or if none, on the most recent date on which there were bid and offered
quotations of a share of Common Stock), as reported by the Nasdaq National
Market or any successor system.

                                       2
<PAGE>

                  (ii) If the Common Stock is at the time listed or admitted to
trading on any national securities exchange, then the Fair Market Value shall be
the closing selling price per share on the date in question on the securities
exchange, as such price is officially quoted in the composite tape of
transactions on such exchange. If there is no reported sale of Common Stock on
such exchange on the date in question, then the Fair Market Value shall be the
closing selling price on the exchange on the last preceding date for which such
quotation exists.

                  (iii) If the Common Stock is not listed on such date on any
national securities exchange nor included in the Nasdaq National Market, but is
traded in the over-the-counter market, the highest "bid" quotation of a share of
Common Stock on such date (or if none, on the most recent date on which there
were bid quotations of a share of Common Stock), as reported on the Nasdaq
Smallcap Market or the NASD OTC Bulletin Board, as applicable.

         (b) Before the Holder shall be entitled to exchange this Debenture for
shares of Common Stock, such Holder shall surrender this Debenture, accompanied
by a proper assignment thereof to the Company or in blank, at the office of the
Company, and shall give written notice to the Company at its principal corporate
office, of the election to convert the same (or a specified portion hereof) and
shall state therein the name or names in which the certificate or certificates
for shares of Common Stock are to be issued. The Company shall, as soon as
practicable thereafter, issue and deliver at such office to the Holder or to the
nominee or nominees of the Holder, a certificate or certificates for the number
of shares of Common Stock to which the Holder shall be entitled as aforesaid,
together with cash in respect of any fraction of a share of Common Stock
issuable upon exchange, and, if applicable, a new Debenture representing the
amount of principal not so exchanged. Such exchange shall be deemed to have been
made immediately prior to the close of business on the date of such surrender of
the Debenture and the person or persons entitled to receive the shares of Common
Stock issuable upon such exchange shall be treated for all purposes as the
record holder or holders of such shares of Common Stock as of such date.

         (c) The Conversion Price shall be subject to adjustment from time to
time as set forth below.

                  (i) In the event the Company should at any time or from time
to time after the date of this Debenture fix a record date for the effectuation
of a split or subdivision of the outstanding shares of Common Stock or the
determination of holders of Common Stock entitled to receive a dividend or other
distribution payable in additional shares of Common Stock or other securities or
rights convertible into, or entitling the holder thereof to receive directly or
indirectly, additional shares of Common Stock (hereinafter referred to as
"Common Stock Equivalents") without payment of any consideration by such holder
for the additional shares of Common Stock or the Common Stock Equivalents
(including the additional shares of Common Stock issuable upon conversion or
exercise thereof), then, as of such record date (or the date of such dividend

                                       3
<PAGE>

distribution, split or subdivision if no record date is fixed), the Conversion
Price shall be appropriately decreased so that the number of shares of Common
Stock issuable on exchange of this Debenture shall be increased in proportion to
such increase in the aggregate number of shares of Common Stock outstanding and
those issuable with respect to such Common Stock Equivalents.

                  (ii) If the number of shares of Common Stock outstanding at
time after the date of this Debenture is decreased by a combination of the
outstanding shares of Common Stock, then, following the record date of such
combination, the Conversion Price shall be appropriately increased so that the
number of shares of Common Stock issuable on exchange of this Debenture shall be
decreased in proportion to such decrease in outstanding shares.

         (d) If at any time or from time to time there shall be a
recapitalization of the Common Stock (other than a subdivision or combination
provided for elsewhere in this Section 5), provision shall be made so that the
Holder shall thereafter be entitled to receive upon exchange of this Debenture
the number of shares of stock or other securities or property of the Company or
otherwise, to which a holder of Common Stock deliverable upon exchange would
have been entitled on such recapitalization. In any such case, appropriate
adjustment shall be made in the application of the provisions of this Section 5
with respect to the rights of the Holder after the recapitalization to the end
that the provisions of this Section 5 (including adjustment of the Conversion
Price then in effect and the number of shares issuable upon exchange of the
Debenture) shall be applicable after that event as nearly equivalently as may be
practicable.

         (e) No fractional shares of Common Stock or scrip representing
fractional shares shall be issued upon the exchange of a Debenture. Instead of
any fractional shares of Common Stock that would otherwise be issuable upon
exchange of a Debenture, the Company shall pay to the Holder a cash adjustment
in respect of such fractional shares in an amount equal to the same fraction of
the Conversion Price then in effect. The determination as to whether or not any
fractional shares are issuable shall be based upon the total principal amount of
Debentures being converted at any one time by any holder thereof, not upon each
Debenture being converted.

         (f) In the event of any taking by the Company of a record of the
holders of any class of securities for the purpose of determining the holders
thereof who are entitled to receive any dividend (other than a cash dividend) or
other distribution, any right to subscribe for, purchase or otherwise acquire
any shares of stock of any class or any other securities or property, or to
receive any other right, the Company shall mail to the Holder at least twenty
(20) days prior to the date specified thereto, a notice specifying the date on
which any such record is to be taken for the purpose of such dividend,
distribution or right, and the amount and character of such dividend,
distribution or right.

         (g) The Company shall at all times reserve and keep available out of
its authorized but unissued shares of Common Stock, solely for the purpose of
effecting the exchange of this Debenture such number of shares of Common Stock
as shall from time

                                       4
<PAGE>

to time be sufficient to effect the exchange of all of the outstanding principal
amount of this Debenture and if at any time the number of authorized but
unissued shares of Common Stock shall not be sufficient to effect the exchange
of this Debenture, in addition to such other remedies as shall be available to
the Holder, the Company will take such corporate action as shall be necessary to
increase the number of authorized but unissued shares of Common Stock to such
number of shares as shall be sufficient for such purposes, including, without
limitation, engaging in best efforts to obtain the requisite stockholder
approval of any necessary amendment to these provisions.

         6. Representations and Warranties of the Company. The Company
represents and warrants that:

         (a) The Company is a corporation duly organized, validly existing and
in good standing under the laws of the state of Delaware. No proceedings to
dissolve the Company are pending or threatened.

         (b) The Company has the power and authority to execute, deliver and
perform this Debenture.

         (c) The execution, delivery, and performance by the Company of this
Debenture: has been duly authorized by all requisite corporate action of the
Company required for the lawful execution, delivery, reaffirmation and
performance hereof; does not, to the Company's knowledge, violate any provisions
of applicable law, rule or regulation; does not violate any judgment, writ,
order, determination, decree or arbitral award of any governmental authority or
arbitral authority binding on the Company or its properties; does not violate
the certificate of incorporation or bylaws of the Company; does not and will not
be in conflict with, result in a breach of or constitute an event of default, or
an event which, with notice or lapse of time or both, would constitute an event
of default, under any contract, indenture, agreement or other instrument or
document to which the Company is a party, or by which the properties or assets
of the Company are bound and such conflict, breach or event of default could
reasonably be expected to result in a material adverse effect on the business,
properties or financial condition of the Company; and, does not and will not
result in the creation or imposition of any lien upon any of the properties or
assets of the Company.

         (d) This Debenture is and shall be the legal, valid and binding
obligation or agreement of the Company enforceable against the Company in
accordance with its terms, subject to the effect of any applicable bankruptcy,
moratorium, insolvency, reorganization or other similar law affecting the
enforceability of creditors' rights generally and to the effect of general
principles of equity (whether considered in a proceeding at law or in equity).

         (e) The Company has delivered to the Holder a copy of the Company's
annual report on Form 10-KSB for the year ended December 31, 2002, and quarterly
report on Form 10-QSB for the quarters ended March 31, 2003 and June 30, 2003
(collectively the "Reports") and neither this Debenture nor any of the Reports
contains any

                                       5
<PAGE>

misrepresentation or untrue statement of material fact or omits to state a
material fact necessary, in light of the circumstances under which it was made,
in order to make any such warranty, representation or statement contained
therein not misleading.

         7. Governing Law. THE COMPANY AND THE HOLDER AGREE THAT THIS DEBENTURE
AND THE LEGAL RELATIONS BETWEEN THE COMPANY AND HOLDER, AND ALL RIGHTS AND
OBLIGATIONS HEREUNDER, INCLUDING MATTERS OF CONSTRUCTION, VALIDITY, AND
PERFORMANCE, SHALL BE GOVERNED BY AND INTERPRETED, CONSTRUED, APPLIED, AND
ENFORCED IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE WITHOUT REFERENCE
TO THE LAW OF ANOTHER JURISDICTION.

         8. Attorney's Fees. If this Debenture is placed with an attorney for
collection, suit be instituted for collection, or any other remedy permitted by
law is pursued by the Holder hereof because of any event of default in the terms
and conditions herein, then in such event, the Company agrees to pay reasonable
attorney's fees, costs, and other expenses incurred by the Holder hereof in so
doing and in enforcing or collecting any judgment rendered therein.

         9. Status of Debenture. This Debenture is a general unsecured
obligation of the Company, and by the acceptance hereof the Holder covenants and
agrees that payment of principal or interest on this Debenture is subordinate to
the payment of all indebtedness of the Company now or hereafter owing to any
secured creditor of the Company regardless of the adequacy of the collateral
pledged or assigned by the Company to any such secured creditor.

         10. Any notice or other communication given pursuant to or in
connection with this Debenture shall be conclusively deemed to have been
received by the Company or the Holder, as the case may be, and be effective (i)
on the day on which delivered (including hand delivery by commercial courier
service) to such party (against receipt there for), (ii) on the date of delivery
to such telefacsimile number for such party, and the receipt of such message is
verified by the sender's telefacsimile machine, or (iii) on the third business
day after the day on which mailed, if sent prepaid by certified or registered
mail, return receipt requested, in each case delivered, transmitted or mailed,
as the case may be, to the address or telefacsimile number, as appropriate, set
forth below or such other address or number as such party shall specify by
notice hereunder:

         (a) if to Company:                Viral Genetics, Inc.
                                           905 Mission Street
                                           South Pasadena, California 91030
                                           Attention: Haig Keledjian, President
                                           Telephone:  (323) 682-2171
                                           Telefacsimile: (323) 799-2265

         (b) if to the Holder:             Tom Little
                                           260 East Chestnut Street
                                           Chicago, Illinois, 60611

                                       6
<PAGE>

                                           Telephone:  ________________
                                           Telefacsimile:______________

         MADE the day and year first above written.

                                           VIRAL GENETICS, INC.

                                           By: __________________________
                                           Name: Haig Keledjian
                                           Title: President

                                       7
<PAGE>

                                   Tom Little
                              260 East Chestnut St.
                                Chicago, IL 60611
--------------------------------------------------------------------------------
                                EXTENSION LETTER

Effective as of December 30, 2003

Viral Genetics, Inc.
905 Mission Street
South Pasadena, CA  91030
ATTN: Haig Keledjian

               RE: Convertible Debenture dated September 30, 2003

Dear Sir:

This letter shall serve as my consent to the extension of the maturity date of
the above-captioned Convertible Debenture (the "Debenture") until July 31, 2004.

I acknowledge that no Event of Default has occurred to the date of this
Extension Letter and that this extension does not in any way constitute a notice
of an Event of Default.

All other terms and conditions of the Debenture shall remain in full force and
effect.

Please indicate your acknowledgment and acceptance of the foregoing effective
the 30th day of December, 2003, by signing below

TOM LITTLE                                             VIRAL GENETICS, INC.

____________________________                           _________________________
                                                       Haig Keledjian, President

                                       8Exhibit 10

Exhibit 10.1

RiT TECHNOLOGIES REPORTS FIRST QUARTER 2004 RESULTS

-- Highest Revenues in 7 Quarters -

  

Tel Aviv, Israel – May 5, 2004 – RiT Technologies (NASDAQ: RITT), the pioneer and world-leading provider of intelligent physical layer solutions, today announced financial results for the first quarter ended March 31, 2004.

Revenues for the first quarter of 2004 were $4,384,000, an increase of 26% compared to $3,485,000 for the first quarter of 2003, and 5% compared to $4,186,000 for the fourth quarter of 2003. Net loss for the quarter declined to ($885,000), or ($0.10) per share, compared to ($1,061,000), or ($0.12) per share for the first quarter of 2003, and ($1,347,000), or ($0.15) per share for the fourth quarter of 2003.

Commenting on the results, Liam Galin, President and CEO, said, “We are proud to report our highest revenues in seven quarters, together with strengthening gross margins and a continued reduction in net loss. For the first time in six years, and in sharp contrast to our normal seasonal pattern, our revenues were higher in the first quarter than they were in the fourth, reflecting the receipt of several repeat Carrier solution orders. In parallel, the cost-cutting put in place over the past two years continues to contribute to the bottom line.

“On the Enterprise side, we are making progress towards closing important new PatchViewTM IPLMS (Intelligent Physical Layer Management Solution) sales. In addition, we have recently launched joint sales activities with NORDX/CDT, our new strategic partner. Although we cannot predict the exact timing of specific orders, we are on track in our plans to rebuild the business and to achieve growth in 2004. We are also encouraged by reawakened interest in our Carrier solutions, as demonstrated by late-stage negotiations in process with five new PairViewTM/ PairQTM customers.”

    

The Company will host a conference call to discuss these results on Wednesday, May 5th, at 10:00 A.M. Eastern Time/ 17:00 Israel time.  To participate, please call 1-800–322-0079 from the US (toll free), or +1-973-935-2407 International, and the ID code: 4722413. 

A replay of the call will be available beginning at 12 noon ET on the day of the call for 14 days by calling 1-877-519-4471 from the US (toll free), or +1-973-341-3080 from the rest of the world ID code: 4722413.

About RiT Technologies

RiT Technologies pioneered the development of intelligent physical layer solutions, designed to provide superior control, utilization and maintenance of networks. RiT's innovative solutions help customers capitalize on network investments and reduce cost of ownership.

RiT's Enterprise Solutions include PatchViewTM for full web-based management, planning and troubleshooting of network physical layer connectivity, and SMART CablingTM System components for single-source, end-to-end structured cabling solutions.

PairViewTM and PairQTM Carrier Solutions help telcos capitalize on outside plant investments by giving them reliable, mass-verified and qualified infrastructure and connectivity databases.

With a global sales network spanning 60 countries, RiT's key customers include major financial institutions, corporations and global telecommunications companies such as: Deutsche Telekom, Alcatel, TELMEX, TELENOR, The New York Mercantile Exchange (NYMEX), ING Barings, INVESCO, DIAGEO, Daewoo, and Reuters.

 

RiT is a member of the RAD group, a world leader in communications solutions.

For more information, please visit our website: www.rittech.com

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: This release contains forward looking statements that are subject to risks and uncertainties, including, but not limited to, the impact of competitive products and pricing, product demand and market acceptance, new product development, reliance on key strategic alliances, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the Company’s filings with the Securities Exchange Commission.

 This press release is available at http://www.rittech.com/ and http://www.portfoliopr.com/

	

RiT TECHNOLOGIES LTD.

	STATEMENTS OF OPERATIONS (U.S GAAP)

	(U.S dollars in thousands, except per share data)

	 	 	 	 	 	 
	 	 	For the three

months ended

March 31,

(Unaudited)

	 
	 	 	 
	 	 	 
	 	 	 
	 	 	2004

	 	2003

	 
	 	 	 	 	 	 
	Sales

	 	4,384

	 	3,485

	 
	Cost of sales

	 	2,504

	 	2,059

	 
	Gross profit

	 	1,880

	 	1,426

	 
	 	 	 	 	 	 
	Operating  cost and expenses:

	 	 	 	 	 
	Research and development, gross

	 	905

	 	892

	 
	Less - royalty-bearing participation

	 	56

	 	85

	 
	Research and development, net

	 	849

	 	807

	 
	 	 	 	 	 	 
	Sales and marketing

	 	1,584

	 	1,382

	 
	 	 	 	 	 	 
	General and administrative

	 	337

	 	323

	 
	Total operating expenses

	 	2,770

	 	2,512

	 
	 	 	 	 	 	 
	Operating loss

	 	(890)

	 	(1,086)

	 
	 	 	 	 	 	 
	Financial income, net

	 	5

	 	25

	 
	 	 	 	 	 	 
	Loss for the period

	 	(885)

	 	(1,061)

	 
	 	 
	Basic and - diluted loss per share 

	 	(0.10)

	 	(0.12)

	 
	

	 	 	 	 	 
	Basic and diluted weighted average number of shares 

	 	8,910,352

	 	8,910,352

	 

	RiT TECHNOLOGIES LTD.

	CONSOLIDATED BALANCE SHEET (U.S GAAP)

	(U.S dollars in thousands)

	 	 	 	 	 
	 	 	March 31, 

2004

	 	December 31, 2003

	 	 	(Unaudited)

	 	(Audited)

	Assets

	 	 	 	 
	Current Assets

	 	 	 	 
	Cash and cash equivalents

	 	1,941

	 	2,714

	Marketable securities

	 	559

	 	560

	Trade, net 

	 	3,484

	 	3,369

	Other 

	 	  831

	 	  767

	Inventories 

	 	4,634

	 	4,760

	Total Current Assets

	 	11,449

	 	12,170

	 	 	 	 	 
	Property and Equipment

	 	 	 	 
	Cost

	 	3,243

	 	3,209

	Less - accumulated depreciation

	 	2,917

	 	2,858

	 	 	326

	 	351

	Assets held for severance benefits

	 	1,392

	 	1,435

	Total Assets

	 	13,167

	 	13,956

	 	 	 	 	 
	Liabilities and Shareholders' Equity

	 	 	 	 
	Current Liabilities

	 	 	 	 
	Trade payables

	 	3,152

	 	3,225

	Other  payables and accrued expenses

	 	2,406

	 	2,153

	Total Current Liabilities

	 	5,558

	 	5,378

	 	 	 	 	 
	Long-term Liabilities

	 	 	 	 
	Liability for  employees severance benefits

	 	1,887

	 	1,970

	Total Long-term Liabilities

	 	1,887

	 	1,970

	Total Liabilities

	 	7,445

	 	7,348

	 	 	 	 	 
	Shareholders' Equity 

	 	 	 	 
	Share capital 

	 	260

	 	260

	Additional paid-in capital

	 	23,928

	 	23,928

	Accumulated other comprehensive income

	 	14

	 	15

	Notes receivable from employees

	 	(27)

	 	(27)

	Accumulated deficit

	 	(18,453)

	 	(17,568)

	Total Shareholders' Equity

	 	5,722

	 	6,608

	Total Liabilities and Shareholders' Equity

	 	13,167

	 	13,956

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00066-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00066-of-00352.parquet"}]]